APA (7th ed.) Citation

Eihuku, T., Miwa, S., Oshima, T., Ohba, H., & Shirai, M. First-line selpercatinib for a patient with RET fusion-positive pulmonary large cell neuroendocrine carcinoma. Elsevier.

Chicago Style (17th ed.) Citation

Eihuku, Tatsuru, Seiichi Miwa, Tomoko Oshima, Hisano Ohba, and Masahiro Shirai. First-line Selpercatinib for a Patient with RET Fusion-positive Pulmonary Large Cell Neuroendocrine Carcinoma. Elsevier.

MLA (9th ed.) Citation

Eihuku, Tatsuru, et al. First-line Selpercatinib for a Patient with RET Fusion-positive Pulmonary Large Cell Neuroendocrine Carcinoma. Elsevier.